文传商讯
Takeda’s TAKHZYRO (lanadelumab) Approved in Japan for Prophylaxis Against Acute Attacks of Heredita
2022-03-30 17:06:50
Galderma to Present New Clinical Data and High Patient Satisfaction Across Their Portfolio of Dermal
2022-03-30 17:06:50
SES Adds Third Satellite from Thales Alenia Space to Extend Services across Europe, Africa and Asia
2022-03-30 17:06:50
Galderma to Highlight Latest Science and Innovation Across Its Product Portfolio at the 2022 AAD Ann
2022-03-28 13:34:37
Galderma to Highlight Latest Science and Innovation Across Its Product Portfolio at the 2022 AAD Ann
2022-03-28 13:34:37
ABB Plans to Launch New Share Buyback of up to $3 Billion Following Completion of 2021-2022 Program
2022-03-28 13:34:37
ViiV Healthcare announces label update for its long-acting HIV treatment, Cabenuva (cabotegravir, ri
2022-03-28 13:34:37
